Atlas Trials

Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation

Clinical trial NCT05446168 · TERMINATED

Trial details

NCT number
NCT05446168
Sponsor
Nicolaas Bohnen, MD, PhD
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson Disease
Start date
2022-07-01
Primary completion
2023-09-26
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.